Home » Topics » Regulatory

Regulatory
RSS

Topical formulation of Targretin launched in U.S. for CTCL therapy

Sep. 28, 2000

Simdax approved in Sweden for severe heart failure

Sep. 28, 2000

Combinations with synergistic antitumor activity claimed by Pharmacia

Sep. 27, 2000

FDA approves Trisenox for APL only three years after U.S. studies began

Sep. 27, 2000

Levaquin tablets/injection approved for new indication in U.S.

Sep. 22, 2000

Once-daily tramadol enters phase III

Sep. 21, 2000

FDA approves QVAR Inhalation Aerosol for treatment of asthma

Sep. 20, 2000

New formulation of Zyprexa introduced for psychotic disorders and manic episodes

Sep. 20, 2000

Glaxo Wellcome seeks new indication for Relenza

Sep. 19, 2000

New HIV treatment option approved by FDA

Sep. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...